Robert Gilmore

7PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisNanomedicineCardiology (incl. cardiovascular diseases)Intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 15, 2026
Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study.

|Apr 08, 2026
Advances in Crohn's Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Emerging Therapeutics.

Yoon-Kyo An, Robert Gilmore, Graham Radford-Smith

|Dec 12, 2025
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium.

Yoon-Kyo An, Niamh Lindsay, Natalie Allan

|May 05, 2025
The Durability of Anti-TNF Therapy for Crohn's Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug Monitoring.

Robert Gilmore, Richard Fernandes, Tamar Schildkraut

|May 31, 2024
Systematic review and meta-analysis of endoscopic versus medical management of peptic ulcers with adherent clots.

Daniel Tassone, Shamsul Kazi, Tanya Lee

|Jul 27, 2023
Factors associated with long-term healthcare expense and steroid exposure in patients admitted with acute severe ulcerative colitis.

Robert Gilmore, Sheng W Lo, Rachael Cheong

Pageof 2

Frequent Collaborators

3 joint publications

Jakob Begun

2 joint publications

Emily K Wright

2 joint publications

Miles P Sparrow

1 joint publications

S Lo